(A) Two-year PFS in patients 60 years and older on S1826 by arm. (B) Two-year OS in patients 60 years and older on S1826 by arm. BV, brentuximab vedotin; HR, hazard ratio; N, nivolumab; OS, overall survival; PFS, progression-free survival. #lymsm #Hodgkin #lymphoma #geriheme

#icml2025 Congrats Dr Juan Manuel Sancho for the excellent presentation! GELTAMO Institut Català d'Oncologia

GELTAMO in #18ICML AGE, FRAILTY, COMORBIDITIES AND FIRST-LINE TREATMENT IMPACT IN SURVIVAL OF ELDERLY HODGKIN LYMPHOMA PATIENTS: GELTAMO RETROSPECTIVE STUDY FROM THE SPANISH GELTAMO GROUP International Conference on Malignant Lymphoma Raul Cordoba, MD, PhD Eva Domingo-Domenech

#18ICML Ana C Oliveira presenting data on BTKi discontinuation in CLL patients @GELLC

#18 ICML Lugano. Ana C Oliveira presenting data pn BTKi discontinuation in CLL patients on behalf of @GELLC

Huge interest in older patients 👵👴 with #Hodgkin #Lymphoma at #18ICML #icml2025. Don’t miss posters P365 by Aisling Barrett, P366 by Peiqi Zhao, and P367 by Eva Domingo-Domenech. There is so much room for improvement in this area. Let’s work together in collaborative projects 🇪🇸🇬🇧🇨🇳 #lymsm

AC Oliveira presenting BTKi discontinuation in CLL patients on behalf of GELLC GRUPO ESPAÑOL DE LEUCEMIA LINFOCITICA CRONICA #18ICML

Congrats Fernando Martín Moro!! Well done 👏🏻👏🏻👏🏻 #18ICML #icml2025

Check our poster “Zanubrutinib in R/R Marginal Zone #Lymphoma: Efficacy and Safety of 101 Spanish Patients Treated in the Real-World on Behalf of GELTAMO” at #ICML2025 #18ICML International Conference on Malignant Lymphoma Great effort of all authors! Fernando Martín Moro Ana Muntañola Antonio Salar

Congrats on Mayo Clinic Urology published study led by Drs Veronica R Bravo and Josep Domingo-Domenech discover that nucleoplasm-residing nucleoporins drive #ProstateCancer progression & immune evasion by switching on oncogenic signaling from deep within the nucleus! vist.ly/3z88z

Congratulations to first authors Kirthika, VJ and Peiyao 👏 👏 👏! Great collaborative effort with Zhu Lab and Veronica R Bravo labs. Also thanks to reviewers and editors Cancer Discovery for positive and constructive feedback.

Proud of you Veronica R Bravo🔝🔝🔝

🩸 Els càncers de la #sang no solen formar tumors, però també són càncers: 🔹Leucèmia 🔹Limfoma 🔹Mieloma Afecten la sang o el sistema limfàtic i necessiten tractaments específics🎯 #CàncerDeLaSang #DubtesCàncer #Hematologia #DiaMundialLeucèmiaMieloideCrònica

Arrancamos la reunión sobre linfoma cutáneo. Empezamos revisando la guía “Modelos de atención multidisciplinar en linfomas” de GELTAMO, con la participación de Eva González Barca. #LinfomaCutáneo #GELTAMO #Salud #Medicina #TrabajoEnEquipo

Linfomas cutaneos en @Geltamo Excelente reunion en Barcelona

At Mayo Clinic Urology published manuscript led by Dr. Josep Domingo-Domenech reviews the role of taxane chemotherapy in the management of #ProstateCancer and highlights future directions to continue improving patient clinical outcomes using this treatment modality. bit.ly/4qUg3A0

#ICOnicPeople!!! Our amazing Cell Therapies group! Congrats Marta, Alberto and everyone on behalf of GETH

Curso en diagnostico y tratamiento del linfoma GELTAMO🔝🔝GELTAMO

GELTAMO está celebrando con éxito la 9ª edición del Curso de Diagnóstico y Tratamiento del Linfoma y la 1ª edición del Curso de Hematopatología en Linfomas

GELTAMO Eva Domingo-Domenech Muchas a Geltamo por la magnífica organización! Tb a Eva Domingo-Domenech nuestra Chair!